Abstract
The wide range of cutaneous clinical features of leprosy arises from the interaction between Mycobacterium leprae and the cell-mediated immunity of patients; clinical aspects can be seen in a spectrum (Ridley–Jopling) which ranges from the tuberculoid (TT) hyperergic pole to the lepromatous (LL) anergic pole. TT is characterized by single or a few lesions (macules, plaques, and papules) grouped together, asymmetric arrangement, well-defined edges, and anesthetic dry surface. LL is characterized by large number of lesions (macules, plaques, and nodules), smooth surface, preserved sensitivity, presence of acid-fast bacilli (AFB), and symmetric distribution pattern. Between these two extreme forms, there is an interpolar or borderline group where it is possible to distinguish BT, BB, and BL. BT leprosy has anesthetic, asymmetric lesions (which include macules, plaques, and papules). In the middle part of the spectrum (BB form), there is high immunological instability with propensity for type 1 leprosy reaction. The BB form is clinically characterized by lesions with symmetric distribution, polymorphic aspect, and AFB presence in lesions. The BL form has symmetric arrangement of lesions (macules, plaques, and nodules), but they are fewer than in the anergic LL form and they contain AFB.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Sehgal VN, Srivastava G. Indeterminate leprosy. A passing phase in the evolution of leprosy. Lepr Rev. 1987;58:291–4.
Nunzi E, Fiallo P. Leprosy: a dichotomous disease. Eur J Dermatol. 1995;5:649–52.
Noto S, Clapasson A, Nunzi E. Classification of leprosy: the mystery of “reactional tuberculoid”. G Ital Dermatol Venereol. 2007;142:294–5.
WHO Expert Committee on Leprosy. WHO Technical report series n. 874. Seventh report; 1988. p. 7.
Uplekar MW, Antia NH. Clinical and histopathological observations on pure neuritic leprosy. Indian J Lepr. 1986;58:513–21.
Jopling WH. Borderline (dimorphous) leprosy maintaining a polyneuritic form for eight years: a case report. Trans R Soc Trop Med Hyg. 1956;50:478–80.
Yoder LJ, Jacobson RR, Job CK. A single skin lesion—an unusual presentation of lepromatous leprosy. Int J Lepr. 1985;53:554–8.
Mascaro JM, Ferrando J, Gratacos R. Lepromatous leprosy clinically localized to one-half of the face. Report of a case. Int J Lepr. 1981;49:315–6.
Maroja MF, Lima LL, Pereira PMR, De Oliveira RML, Massone C. Zoster-like segmental presentation of Lepromatous leprosy. Lepr Rev. 2010;81(3):224–7.
Taylor PM. The clinical diagnosis of dapsone resistant leprosy. Lepr India. 1982;54:117–22.
Price EW, Fitzhebert M. Histoid (high-resistance) lepromatous leprosy. Int J Lepr. 1966;34:367–74.
Kroll JJ, Shapiro L. The histoid variety of lepromatous leprosy. Int J Dermatol. 1973;13:74–8.
Azulay-Abulafia L, Pereira Spinelli L, Hardmann D, et al. Lucio phenomenon. Vasculitis or occlusive vasculopathy? Hautartz. 2006;57:1101–5.
Nunzi E, Ortega Cabrera LV, Macanchi Monca Yo FM, Ortega Espinosa PF, Clapasson A, Massone C. Lucio Leprosy with Lucio’s phenomenon, digital gangrene and cardiolipin antibodies. Lepr Rev. 2014;85:194–200.
Fiallo P, Travaglino C, Nunzi E, et al. Beta2-glycoprotein I-dependence of cardiolipin antibodies in multibacillary leprosy patients. Lepr Rev. 1998;69:376–81.
WHO. Guidelines for the diagnosis, treatment and prevention of leprosy; 2018.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nunzi, E., Massone, C., Noto, S. (2022). Clinical Features of Leprosy. In: Nunzi, E., Massone, C., Portaels, F. (eds) Leprosy and Buruli Ulcer. Springer, Cham. https://doi.org/10.1007/978-3-030-89704-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-030-89704-8_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-89703-1
Online ISBN: 978-3-030-89704-8
eBook Packages: MedicineMedicine (R0)